Response Genetics, Inc./ US76123U1051 /
15/05/2023 18:32:09 | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0000USD | - | 77,000 Turnover: .0770 |
-Bid Size: - | -Ask Size: - | 0.0000 | 0.0000 |
GlobeNewswire
05/10/2021
Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a...
GlobeNewswire
04/10/2021
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
GlobeNewswire
26/10/2020
Rockefeller University Scientist Uses Bionano Saphyr to Analyze Genomes of Patients and Animals Susc...
GlobeNewswire
09/07/2018
Global Strategic Business Outlook on the Genetic Testing Market 2016-2018 to 2024: Ballooning Global...
GlobeNewswire
29/05/2018
Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action La...
GlobeNewswire
25/05/2018
CGIX $100,000 Threshold: Law Offices of Howard G. Smith Announces the Filing of a Securities Class A...
GlobeNewswire
08/05/2018
CANCER GENETICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a fed...
GlobeNewswire
06/05/2018
Kaskela Law LLC: Shareholder Class Action Filed Against Cancer Genetics, Inc. - CGIX
GlobeNewswire
28/04/2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cancer...
GlobeNewswire
18/04/2018
Pomerantz Law Firm Announces the Filing of a Class Action against Cancer Genetics, Inc. and Certain ...
GlobeNewswire
11/04/2018
WOLF HALDENSTEIN: CANCER GENETICS, INC. INVESTOR ALERT - Wolf Haldenstein Adler Freeman & Herz LLP a...
GlobeNewswire
02/04/2018
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic B...
GlobeNewswire
21/02/2018
Global Healthcare Attorney Hourly Rate Report 2018: Hourly Rates of Attorneys, Partners, Counsel, Se...
GlobeNewswire
05/09/2017
Opiant Pharmaceuticals, Inc. Announces Appointment of David O’Toole as Chief Financial Officer
GlobeNewswire
20/03/2017
SWK Holdings Corporation Announces 2016 Fourth Quarter and Full-Year Financial Results